The system was cleared by the FDA in August and is expected to see a full market release in the first quarter of 2024, according to a Nov. 28 press release.
The Integrity implant is a flexible, knitted, HA-based scaffold that provides improved dry and wet strength and regenerative capacity over first-generation collagen patches. It supports regenerative healing through improved cell infiltration, tissue remodeling and tendon thickening.
The system demonstrates greater regenerative capacity as early as 12 weeks post-implantation. At 26 weeks, the Integrity system forms a new network of tendon tissues.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
